Sartorius launched the CellCelector CLD, an automated imaging and cell isolation platform designed to compress monoclonal cell line development timelines. The system is built to scan and track clonal growth, then isolate high-performing clones with gentle retrieval to maintain viability and traceability. The company claims the workflow can reduce months of manual setup to roughly seven weeks, while increasing monoclonal well yields and clone outgrowth versus standard approaches. It also includes an EMA 410-compliant productivity assay to document productivity-related selection decisions from early stages. For upstream process development teams, the core value proposition is operational speed without sacrificing documentation needed for regulatory expectations, potentially improving responsiveness when sponsors need rapid cell-line lock and tech transfer.